Outsourcing is driving biopharma efficiency and scale, including in the drug discovery area and early phase development.
A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...
CAMBRIDGE, Mass., February 12, 2026 - Insilico Medicine (3696.HK), a clinical-stage, generative AI-driven drug discovery company, today announced the launch of a new interactive webpage highlighting ...
Whether a smartphone battery lasts longer or a new drug can be developed to treat incurable diseases depends on how stably ...
In a year from now, progress is to be measured in the institutionalisation of the approach with greater regulatory acceptance ...
While physicians and scientists have long known that Alzheimer's disease involves the buildup of toxic protein fragments in ...
AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.
Leveraging its integrated "design-synthesis-quality control" system, Creative Biolabs is overcoming bottlenecks in mRNA ...
There’s no doubt that large language models and generative AI tools have taken the world by storm. Their ability to create, ...
Whether a smartphone battery lasts longer or a new drug can be developed to treat incurable diseases depends on how stably the atoms constituting the material are bonded. The core of 'molecular design ...
Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.
Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results